Armitage: “I am doing what I can” to keep Kappos at USPTO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Armitage: “I am doing what I can” to keep Kappos at USPTO

armitage-45.jpg

Following an announcement that he will retire as Eli Lilly’s senior vice president and general counsel at the end of this year, Robert Armitage would not indicate whether he is interested in taking over as USPTO director, instead saying he is urging Kappos to stay on

armitage.jpg

Armitage has been a leading figure in patent law for over 30 years, and was actively involved in the creation and enactment of the AIA. He will be replaced by Michael Harrington, who has been promoted from vice president and deputy general counsel, global pharmaceutical operations at Eli Lilly, effective January 1 2013.

Although Armitage said he has not decided on next steps following his retirement, he is on the IP community’s list of potential Democratic party candidates to replace David Kappos as USPTO director. While Kappos may choose to stay on if President Barack Obama is re-elected, Managing IP sources have indicated he may want to leave.

When asked if he would consider the USPTO position, Armitage described Kappos as “a uniquely talented and able director”. He added: “I am doing what I can to urge him to continue in the role, to see many of the transformational changes in the USPTO to a successful conclusion.”



more from across site and SHARED ros bottom lb

More from across our site

In-house counsel explain why firms should provide risk management advice that helps them achieve their goals
Attorneys at four firms explain the AI trends they expect in the future, including a potential shift in who plaintiffs sue for copyright infringement
The dispute at the Intellectual Property Enterprise Court pits Dryrobe against D-Robe and will include a ‘genericide’ element
Novo Nordisk losing patent rights covering Ozempic in Canada and a US Supreme Court decision favouring Ed Sheeran were also among the top talking points
The court will hand down its ruling in Iconix v Dream Pairs on Tuesday, June 24, in a case that concerns post-sale confusion
Developments included a stay in a row concerning the UPC’s jurisdiction and a timeline for the rollout of the long-awaited new CMS
Jorg Thomaier, who has been head of IP at the German pharma company since 2010, will leave later this year and hand the reins to the company’s head of patents
Companies must conduct thorough IP due diligence – even if it may not be mandatory
Celia Cheah at Wong & Partners in Malaysia says she is aiming to tap into the Baker McKenzie member firm’s international network and expand its IP portfolio
A team of partners that joined Boies Schiller Flexner say they would like to double the firm’s patent litigation capabilities
Gift this article